Skip to main content

Site notifications

(Approval lapsed) Amoxicillin 125mg/5ml Oral Suspension Sugar Free BP (Athlone)

Section 19A approved medicine
(Approval lapsed) Amoxicillin 125mg/5ml Oral Suspension Sugar Free BP (Athlone)
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
Phone
0422 429 648
Approved until
Status
Expired
Medicines in short supply/unavailable
APO-AMOXYCILLIN amoxicillin (as trihydrate) 125mg/5mL powder for suspension bottle - ARTG 137882
Indication(s)

It is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms.

Note. Therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. However, in emergency cases where the causative organism has not been identified, therapy with amoxicillin may be useful. Clinical judgment will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results.

  • Skin and skin structure: Staphylococcus, nonpenicillinase producing; Streptococcus; E. coli.
  • Respiratory tract (acute and chronic): H. influenzae; Streptococcus; S. pneumoniae; Staphylococcus, nonpenicillinase producing; E. coli.
  • Genitourinary tract (complicated and uncomplicated, acute and chronic): E.coli P.mirabilis and Strep. faecalis.
  • Gonorrhoea: N. gonorrhoea (nonpencillinase producing).
  • Prophylaxis of endocarditis: Amoxicillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.
Images
Picture of Amoxicillin 125mg/5ml Oral Suspension Sugar Free BP (Athlone)

Help us improve the Therapeutic Goods Administration site